Purdue Pharma to be sentenced in criminal opioids case, allowing settlement money to flow
Context:
A judge is poised to order Purdue Pharma to forfeit $225 million as part of a settlement ending federal probes into its role in the opioid crisis, clearing the path for a broader agreement that aims to resolve thousands of lawsuits. The deal requires the Sackler family to contribute up to billions over 15 years, and would reorganize Purdue into Knoa Pharma to operate for the public benefit, subject to state-appointed oversight. While the settlement addresses liability for vast opioid sales and marketing practices, victims’ advocates argue it falls short of true accountability. With sentencing imminent, victims’ families are pressing for continued criminal scrutiny and accountability beyond the financial settlement, as the crisis persists. The arrangement could take effect soon, shifting resources toward overdose prevention and crisis response while reshaping the company’s future.
Dive Deeper:
Purdue Pharma pleaded guilty in 2020 to three federal criminal charges related to failing to prevent diversion of opioids and paying doctors to prescribe them, signaling a critical turning point in its legal saga.
The broader settlement would replace Purdue with Knoa Pharma, a new entity intended to operate for the public good, with a board appointed by the states and a reorganization described as highly complex.
The Sackler family, owners of the company, would be required to contribute up to billions over 15 years in settlements with states, local governments, Native American tribes, and some victims, while receiving protections from further opioid-related lawsuits.
More than 54,000 claimants supported the settlement, while a small number of victims’ families opposed it, arguing that it does not fully deliver justice or criminal accountability.
The case has been marked by long legal twists, with жillions of dollars already paid to various law firms and parties, and ongoing battles over how the funds should be used to combat the overdose epidemic.
Victims’ advocates have highlighted concerns that some governments have not yet effectively utilized funds allocated to fight the crisis, pushing for continued investigations and accountability beyond the settlement.